Literature DB >> 1710022

Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing.

G A Rodrigues1, M A Naujokas, M Park.   

Abstract

The met proto-oncogene is a member of the family of tyrosine kinase growth factor receptors. We describe the isolation and characterization of a cDNA clone (pOK) for the met receptor from a gastric carcinoma cell line. This clone differs from the published cDNA clone by the absence of 54 bp predicted to encode 18 amino acids in the extracellular domain. The pOK cDNA corresponds to the most abundant met RNA species of 8 kb expressed in human cell lines and tissue, and we show that there are in fact two 8-kb met receptor tyrosine kinase (RTK) isoforms that are generated by alternative splicing. This newly described met isoform when transiently expressed in COS cells encodes a protein of 190 kDa which corresponds in size to the p190 met alpha beta heterodimer expressed in human cell lines. Furthermore, we show that the 190-kDa product of pOK consists of the 140-kDa met beta subunit associated with the 50-kDa met alpha subunit. This finding suggests that both the alpha and beta met chains are encoded by this construct and confirms the hypothesis that a single chain precursor is cleaved to produce both subunits of met. In contrast, the previously characterized met isoform corresponds to a minor met RNA species and encodes a protein of 170 kDa that is not cleaved yet is processed in a manner that allows cell surface expression. Both met RTK isoforms are autophosphorylated in the in vitro kinase assay. These results suggest that different isoforms of the met RTK may have distinct biological activities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710022      PMCID: PMC360125          DOI: 10.1128/mcb.11.6.2962-2970.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

Authors:  J H McCutchan; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

2.  Catalysis of iodination by lactoperoxidase.

Authors:  M Morrison; G S Bayse
Journal:  Biochemistry       Date:  1970-07-21       Impact factor: 3.162

3.  Molecular cloning of a new transforming gene from a chemically transformed human cell line.

Authors:  C S Cooper; M Park; D G Blair; M A Tainsky; K Huebner; C M Croce; G F Vande Woude
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

4.  Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.

Authors:  F Coulier; R Kumar; M Ernst; R Klein; D Martin-Zanca; M Barbacid
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

5.  The activated human met gene encodes a protein tyrosine kinase.

Authors:  P R Tempest; C S Cooper; G N Major
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

6.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

7.  A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue.

Authors:  L A Petch; J Harris; V W Raymond; A Blasband; D C Lee; H S Earp
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

8.  High efficiency polyoma DNA transfection of chloroquine treated cells.

Authors:  H Luthman; G Magnusson
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Functionally distinct insulin receptors generated by tissue-specific alternative splicing.

Authors:  L Mosthaf; K Grako; T J Dull; L Coussens; A Ullrich; D A McClain
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

View more
  48 in total

1.  The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M Holgado-Madruga; I Royal; M A Naujokas; T M Fournier; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion.

Authors:  T M Fournier; L Lamorte; C R Maroun; M Lupher; H Band; W Langdon; M Park
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

3.  The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M A Naujokas; M Holgado-Madruga; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

Authors:  S Yi; M S Tsao
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

5.  Chromosomal localization of rat hepatocyte growth factor (Hgf) and HGF receptor (Met) and characterization of HGF receptor cDNA.

Authors:  V R Wallenius; H Rawet; S Skrtic; K Helou; Y Qiu; G Levan; S Ekberg; B Carlsson; O G Isaksson; T Nakamura; J O Jansson
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

6.  Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesis.

Authors:  Lisa S Lock; Christiane R Maroun; Monica A Naujokas; Morag Park
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

7.  Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.

Authors:  V Wallenius; M Hisaoka; K Helou; G Levan; N Mandahl; J M Meis-Kindblom; L G Kindblom; J O Jansson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

8.  Distinct recruitment of Eps15 via Its coiled-coil domain is required for efficient down-regulation of the met receptor tyrosine kinase.

Authors:  Christine A Parachoniak; Morag Park
Journal:  J Biol Chem       Date:  2008-12-24       Impact factor: 5.157

9.  Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.

Authors:  Veena Sangwan; Grigorios N Paliouras; Jasmine V Abella; Nadia Dubé; Anie Monast; Michel L Tremblay; Morag Park
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

10.  A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype.

Authors:  C Collesi; M M Santoro; G Gaudino; P M Comoglio
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.